Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
NRC Health Common Stock
NRC
$434M
| $4.52M | ﹤0.01% |
114,089
+1,470
| +1% | +$58.1K |
|
2327
GoPro
GPRO
$133M
| $4.48M | ﹤0.01% |
2,007,227
+329,432
| +20% | +$880K |
|
|
LAZR
2328
DELISTED
Luminar Technologies
LAZR
| $4.47M | ﹤0.01% |
151,331
+27,355
| +22% | +$998K |
|
|
WOW
2329
DELISTED
WideOpenWest
WOW
| $4.45M | ﹤0.01% |
1,229,125
+244,308
| +25% | +$872K |
|
2330
Novavax
NVAX
$1.26B
| $4.45M | ﹤0.01% |
930,220
+169,887
| +22% | +$788K |
|
2331
Teekay
TK
$977M
| $4.44M | ﹤0.01% |
610,166
+319,152
| +110% | +$2.5M |
|
2332
NerdWallet
NRDS
$609M
| $4.42M | ﹤0.01% |
300,941
-1,503
| -0.5% | -$23.2K |
|
2333
Cullinan Oncology
CGEM
$1.08B
| $4.39M | ﹤0.01% |
257,873
+11,168
| +5% | +$173K |
|
|
GOOD
2334
Gladstone Commercial Corp
GOOD
$608M
| $4.35M | ﹤0.01% |
314,187
+3,884
| +1% | +$50.5K |
|
|
TRST
2335
Trustco Bank Corp NY
TRST
$983M
| $4.32M | ﹤0.01% |
153,583
+4,889
| +3% | +$138K |
|
|
ALX
2336
Alexander's
ALX
$1.4B
| $4.31M | ﹤0.01% |
19,866
+3,496
| +21% | +$762K |
|
2337
Travere Therapeutics
TVTX
$5.21B
| $4.28M | ﹤0.01% |
555,472
+15,985
| +3% | +$135K |
|
2338
Centrus Energy
LEU
$3.72B
| $4.27M | ﹤0.01% |
102,779
+3,208
| +3% | +$147K |
|
2339
Sony
SONY
$131B
| $4.25M | ﹤0.01% |
247,700
+36,305
| +17% | +$667K |
|
2340
Caribou Biosciences
CRBU
$156M
| $4.24M | ﹤0.01% |
824,657
+16,898
| +2% | +$104K |
|
2341
Ubiquiti
UI
$33.9B
| $4.23M | ﹤0.01% |
36,485
+308
| +0.9% | +$37.8K |
|
2342
Summit Therapeutics
SMMT
$11B
| $4.21M | ﹤0.01% |
1,016,545
+62,699
| +7% | +$249K |
|
2343
Unilever
UL
$138B
| $4.19M | ﹤0.01% |
74,166
+26,938
| +57% | +$1.49M |
|
2344
Weave Communications
WEAV
$547M
| $4.18M | ﹤0.01% |
364,048
+4,882
| +1% | +$58.7K |
|
2345
Nuvation Bio
NUVB
$2.24B
| $4.18M | ﹤0.01% |
1,148,027
+21,364
| +2% | +$41K |
|
2346
TETRA Technologies
TTI
$1.28B
| $4.18M | ﹤0.01% |
942,716
+11,765
| +1% | +$48.9K |
|
2347
Beyond Meat
BYND
$327M
| $4.17M | ﹤0.01% |
504,170
+80,458
| +19% | +$619K |
|
2348
Corsair Gaming
CRSR
$1.22B
| $4.16M | ﹤0.01% |
337,262
+7,806
| +2% | +$101K |
|
2349
Cogent Biosciences
COGT
$7.32B
| $4.16M | ﹤0.01% |
619,036
+13,007
| +2% | +$80.4K |
|
|
BFS
2350
Saul Centers
BFS
$838M
| $4.14M | ﹤0.01% |
107,531
+2,682
| +3% | +$102K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.